Exploiting interleukin 6 in multicentric Castleman's disease

被引：10

作者：

Bower, Mark ^{[1
]}

Stebbing, Justin

机构：

[1] Chelsea & Westminster Hosp, Natl Ctr HIV Malignancy, London SW10 9NH, England

来源：

LANCET ONCOLOGY | 2014年 / 15卷 / 09期

关键词：

D O I：

10.1016/S1470-2045(14)70333-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：910 / 912

页数：4

共 10 条

[1] Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 [J].

Aoki, Y ;

Jaffe, ES ;

Chang, Y ;

Jones, K ;

Teruya-Feldstein, J ;

Moore, PS ;

Tosato, G .

BLOOD, 1999, 93 (12) :4034-4043

[2] Diagnostic Criteria Schemes for Multicentric Castleman Disease in 75 Cases [J].

Bower, Mark ;

Dalla Pria, Alessia ;

Coyle, Christopher ;

Nelson, Mark ;

Naresh, Kikkeri .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (02) :E80-E82

[3] Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease [J].

Bower, Mark ;

Newsom-Davis, Tom ;

Naresh, Kikkeri ;

Merchant, Shairoz ;

Lee, Belinda ;

Gazzard, Brian ;

Stebbing, Justin ;

Nelson, Mark .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) :2481-2486

[4] HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy [J].

Fajgenbaum, David C. ;

van Rhee, Frits ;

Nabel, Christopher S. .

BLOOD, 2014, 123 (19) :2924-2933

[5] Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice [J].

Katsume, A ;

Saito, H ;

Yamada, Y ;

Yorozu, K ;

Ueda, O ;

Akamatsu, K ;

Nishimoto, N ;

Kishimoto, T ;

Yoshizaki, K ;

Ohsugi, Y .

CYTOKINE, 2002, 20 (06) :304-311

[6] High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients [J].

Oksenhendler, E ;

Carcelain, G ;

Aoki, Y ;

Boulanger, E ;

Maillard, A ;

Clauvel, JP ;

Agbalika, F .

BLOOD, 2000, 96 (06) :2069-2073

[7] KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-LIKE DNA-SEQUENCES IN MULTICENTRIC CASTLEMANS DISEASE [J].

SOULIER, J ;

GROLLET, L ;

OKSENHENDLER, E ;

CACOUB, P ;

CAZALSHATEM, D ;

BABINET, P ;

DAGAY, MF ;

CLAUVEL, JP ;

RAPHAEL, M ;

DEGOS, L ;

SIGAUX, F .

BLOOD, 1995, 86 (04) :1276-1280

[8] Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels [J].

Stone, Katie ;

Woods, Emily ;

Szmania, Susann M. ;

Stephens, Owen W. ;

Garg, Tarun K. ;

Barlogie, Bart ;

Shaughnessy, John D., Jr. ;

Hall, Brett ;

Reddy, Manjula ;

Hoering, Antje ;

Hansen, Emily ;

van Rhee, Frits .

PLOS ONE, 2013, 8 (01)

[9] High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy [J].

Uldrick, Thomas S. ;

Polizzotto, Mark N. ;

Aleman, Karen ;

O'Mahony, Deirdre ;

Wyvill, Kathleen M. ;

Wang, Victoria ;

Marshall, Vickie ;

Pittaluga, Stefania ;

Steinberg, Seth M. ;

Tosato, Giovanna ;

Whitby, Denise ;

Little, Richard F. ;

Yarchoan, Robert .

BLOOD, 2011, 117 (26) :6977-6986

[10]

van Rhee F, 2014, LANCET ONCOL

← 1 →